Can-Fite BioPharma Ltd. SEC filings CANF
Can-Fite BioPharma Ltd. has 865 filings in SEC EDGAR's recent list, going back to Dec 1, 2011. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 2, 2026 | Nov 2, 2026 |
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| EFFECT | Filing | Oct 9, 2026 | — |
| EFFECT | Filing | Oct 9, 2026 | — |
| 424B3 | Prospectus | Oct 9, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 25, 2026 | — |
| F-3/A | Amendment no. 1 to form f-3 | Sep 25, 2026 | — |
| EFFECT | Filing | Sep 11, 2026 | — |
| EFFECT | Filing | Sep 11, 2026 | — |
| D | Filing | Sep 10, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| POS AM | Post-effective amendment no. 11 to form f-1 | Sep 8, 2026 | — |
| POS AM | Post-effective amendment no. 11 to form f-1 | Sep 8, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 3, 2026 | Sep 3, 2026 |
| 6-K | Current report (foreign issuer) | Sep 2, 2026 | Sep 2, 2026 |
| 6-K | Current report (foreign issuer) | Sep 2, 2026 | Sep 2, 2026 |
| F-3 | Shelf registration (foreign issuer) | Aug 28, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 17, 2026 | Aug 17, 2026 |
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Aug 12, 2026 |
| 6-K | Current report (foreign issuer) | Aug 3, 2026 | Aug 3, 2026 |
| 6-K | Current report (foreign issuer) | Jul 20, 2026 | Jul 20, 2026 |
| 6-K | Current report (foreign issuer) | Jul 14, 2026 | Jul 14, 2026 |
| 6-K | Current report (foreign issuer) | Jul 6, 2026 | Jul 6, 2026 |
| 6-K | Current report (foreign issuer) | Jul 1, 2026 | Jul 1, 2026 |
| 6-K | Current report (foreign issuer) | Jun 26, 2026 | Jun 26, 2026 |
| 6-K | Current report (foreign issuer) | Jun 22, 2026 | Jun 22, 2026 |
| 6-K | Current report (foreign issuer) | Jun 17, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 6-K | Current report (foreign issuer) | Jun 4, 2026 | Jun 4, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 2, 2026 |
| 6-K | Current report (foreign issuer) | May 28, 2026 | May 28, 2026 |
| 6-K | Current report (foreign issuer) | May 18, 2026 | May 18, 2026 |
| 6-K | Current report (foreign issuer) | May 13, 2026 | May 13, 2026 |
| 6-K | Current report (foreign issuer) | Apr 30, 2026 | Apr 30, 2026 |
| 6-K | Current report (foreign issuer) | Apr 23, 2026 | Apr 23, 2026 |
| 3 | Initial insider ownership | Apr 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 6, 2026 | Mar 18, 2026 |
| EFFECT | Filing | Apr 3, 2026 | — |
| 424B3 | Prospectus | Apr 3, 2026 | — |
| CORRESP | Letter to the SEC | Apr 1, 2026 | — |
| EFFECT | Filing | Mar 31, 2026 | — |
| EFFECT | Filing | Mar 31, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 31, 2026 | — |
| POS AM | Post-effective amendment no. 9 to form f-1 | Mar 31, 2026 | — |
| POS AM | Post-effective amendment no. 9 to form f-1 | Mar 31, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 30, 2026 | Mar 30, 2026 |
| 20-F | Annual report (foreign issuer) | Mar 26, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 26, 2026 | Mar 26, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 17, 2026 | Mar 17, 2026 |
| 6-K | Current report (foreign issuer) | Mar 10, 2026 | Mar 10, 2026 |
| 424B3 | Prospectus | Mar 5, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 5, 2026 | Mar 5, 2026 |
| 6-K | Current report (foreign issuer) | Mar 4, 2026 | Mar 4, 2026 |
| 6-K | Current report (foreign issuer) | Mar 3, 2026 | Mar 3, 2026 |
| 6-K | Current report (foreign issuer) | Feb 17, 2026 | Feb 17, 2026 |
| 6-K | Current report (foreign issuer) | Feb 9, 2026 | Feb 9, 2026 |
| 6-K | Current report (foreign issuer) | Feb 5, 2026 | Feb 5, 2026 |
| 6-K | Current report (foreign issuer) | Jan 27, 2026 | Jan 27, 2026 |
| 6-K | Current report (foreign issuer) | Jan 20, 2026 | Jan 20, 2026 |
| 6-K | Current report (foreign issuer) | Jan 16, 2026 | Jan 16, 2026 |
| 6-K | Current report (foreign issuer) | Dec 29, 2025 | Dec 29, 2025 |
| 6-K | Current report (foreign issuer) | Dec 23, 2025 | Dec 23, 2025 |
| 6-K | Current report (foreign issuer) | Dec 16, 2025 | Dec 16, 2025 |
| 424B3 | Prospectus | Nov 21, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 21, 2025 | Nov 21, 2025 |
| 6-K | Current report (foreign issuer) | Nov 20, 2025 | Nov 20, 2025 |
| 6-K | Current report (foreign issuer) | Nov 18, 2025 | Nov 18, 2025 |
| 6-K | Current report (foreign issuer) | Nov 10, 2025 | Nov 10, 2025 |
| 6-K | Current report (foreign issuer) | Nov 3, 2025 | Nov 3, 2025 |
| 6-K | Current report (foreign issuer) | Oct 3, 2025 | Oct 3, 2025 |
| 6-K | Current report (foreign issuer) | Sep 15, 2025 | Sep 15, 2025 |
| EFFECT | Filing | Sep 11, 2025 | — |
| EFFECT | Filing | Sep 11, 2025 | — |
| POS AM | Post-effective amendment no. 9 to form f-1 | Sep 8, 2025 | — |
| POS AM | Post-effective amendment no. 9 to form f-1 | Sep 8, 2025 | — |
| POS AM | Post-effective amendment no. 8 to form f-1 | Sep 8, 2025 | — |
| POS AM | Post-effective amendment no. 8 to form f-1 | Sep 8, 2025 | — |
| POS AM | Post-effective amendment no. 7 to form f-1 | Aug 28, 2025 | — |
| POS AM | Post-effective amendment no. 7 to form f-1 | Aug 28, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 28, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 30, 2025 | Jul 30, 2025 |
| 424B4 | Prospectus | Jul 29, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 29, 2025 | Jul 29, 2025 |
| EFFECT | Filing | Jul 28, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 28, 2025 | Jul 28, 2025 |
| 6-K | Current report (foreign issuer) | Jul 28, 2025 | Jul 28, 2025 |
| F-1/A | Amendment no. 1 to form f-1 | Jul 25, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Jul 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2025 | — |
| CORRESP | Letter to the SEC | Jul 17, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2025 | — |
| DRS | Filing | Jul 9, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 30, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jun 23, 2025 | Jun 23, 2025 |
| UPLOAD | Letter from the SEC | Jun 17, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 16, 2025 | Jun 16, 2025 |
| 6-K | Current report (foreign issuer) | May 16, 2025 | May 16, 2025 |
| 424B5 | Prospectus supplement | May 9, 2025 | — |
| 6-K | Current report (foreign issuer) | May 5, 2025 | May 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 23, 2025 | — |
| EFFECT | Filing | Apr 17, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 17, 2025 | Apr 17, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 16, 2025 | — |
| 424B5 | Prospectus supplement | Apr 15, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 15, 2025 | Apr 15, 2025 |
| 6-K | Current report (foreign issuer) | Apr 14, 2025 | Apr 14, 2025 |
| POS AM | Post-effective amendment no. 8 to form f-1 | Apr 14, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 14, 2025 | Apr 14, 2025 |
| 6-K | Current report (foreign issuer) | Apr 14, 2025 | Apr 14, 2025 |
| 20-F | Annual report (foreign issuer) | Apr 14, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 24, 2025 | Mar 24, 2025 |
| 6-K | Current report (foreign issuer) | Mar 20, 2025 | Mar 20, 2025 |
| 6-K | Current report (foreign issuer) | Mar 19, 2025 | Mar 19, 2025 |
| 6-K | Current report (foreign issuer) | Mar 18, 2025 | Mar 18, 2025 |
| 6-K | Current report (foreign issuer) | Mar 3, 2025 | Mar 3, 2025 |
| 6-K | Current report (foreign issuer) | Feb 18, 2025 | Feb 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 6-K | Current report (foreign issuer) | Feb 5, 2025 | Feb 5, 2025 |
| 6-K | Current report (foreign issuer) | Jan 27, 2025 | Jan 27, 2025 |
| 6-K | Current report (foreign issuer) | Dec 30, 2024 | Dec 30, 2024 |
| 6-K | Current report (foreign issuer) | Dec 4, 2024 | Dec 4, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 12, 2024 | Nov 11, 2024 |
| 6-K | Current report (foreign issuer) | Nov 4, 2024 | Nov 4, 2024 |
| 6-K | Current report (foreign issuer) | Oct 18, 2024 | Oct 18, 2024 |
| 6-K | Current report (foreign issuer) | Oct 9, 2024 | Oct 9, 2024 |
| 6-K | Current report (foreign issuer) | Sep 24, 2024 | Sep 24, 2024 |
| 6-K | Current report (foreign issuer) | Sep 16, 2024 | Sep 16, 2024 |
| EFFECT | Filing | Sep 6, 2024 | — |
| 424B3 | Prospectus | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 6, 2024 | — |
| EFFECT | Filing | Sep 5, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2024 | — |
| 6-K | Current report (foreign issuer) | Aug 30, 2024 | Aug 30, 2024 |
| F-3 | Shelf registration (foreign issuer) | Aug 30, 2024 | — |
| POS AM | Post-effective amendment no. 7 to form f-1 | Aug 30, 2024 | — |
| 424B5 | Prospectus supplement | Aug 30, 2024 | — |
| 6-K | Current report (foreign issuer) | Aug 29, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 12, 2024 | Aug 12, 2024 |
| 6-K | Current report (foreign issuer) | Aug 9, 2024 | Aug 9, 2024 |
| 6-K | Current report (foreign issuer) | Jul 29, 2024 | Jul 29, 2024 |
| 6-K | Current report (foreign issuer) | Jul 11, 2024 | Jul 11, 2024 |
| 6-K | Current report (foreign issuer) | Jul 3, 2024 | Jul 3, 2024 |
| 6-K | Current report (foreign issuer) | Jul 1, 2024 | Jul 1, 2024 |
| 424B7 | Prospectus supplement | Jun 28, 2024 | — |
| 6-K | Current report (foreign issuer) | Jun 28, 2024 | Jun 28, 2024 |
| 6-K | Current report (foreign issuer) | Jun 26, 2024 | Jun 26, 2024 |
| 6-K | Current report (foreign issuer) | Jun 24, 2024 | Jun 24, 2024 |
| 6-K | Current report (foreign issuer) | Jun 10, 2024 | Jun 10, 2024 |
| 6-K/A | Amendment no. 1 to form 6-k | Jun 7, 2024 | Jun 7, 2024 |
| 6-K | Current report (foreign issuer) | Jun 5, 2024 | Jun 5, 2024 |
| 6-K | Current report (foreign issuer) | May 29, 2024 | May 29, 2024 |
| 6-K | Current report (foreign issuer) | May 22, 2024 | May 22, 2024 |
| 6-K | Current report (foreign issuer) | May 13, 2024 | May 13, 2024 |
| 6-K | Current report (foreign issuer) | May 9, 2024 | May 9, 2024 |
| 6-K | Current report (foreign issuer) | May 6, 2024 | May 6, 2024 |
| 6-K | Current report (foreign issuer) | Apr 25, 2024 | Apr 25, 2024 |
| 6-K | Current report (foreign issuer) | Apr 15, 2024 | Apr 15, 2024 |
| EFFECT | Filing | Apr 9, 2024 | — |
| S-8 | Employee stock plan registration | Apr 5, 2024 | — |
| POS AM | Post-effective amendment no. 6 to form f-1 | Apr 5, 2024 | — |
| 6-K | Current report (foreign issuer) | Apr 3, 2024 | Apr 3, 2024 |
| 20-F | Annual report (foreign issuer) | Mar 28, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 28, 2024 | Mar 28, 2024 |
| 6-K | Current report (foreign issuer) | Mar 11, 2024 | Mar 11, 2024 |
| 6-K | Current report (foreign issuer) | Feb 28, 2024 | Feb 28, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| 6-K | Current report (foreign issuer) | Jan 30, 2024 | Jan 30, 2024 |
| 6-K | Current report (foreign issuer) | Jan 29, 2024 | Jan 29, 2024 |
| EFFECT | Filing | Jan 5, 2024 | — |
| CORRESP | Letter to the SEC | Jan 3, 2024 | — |
| F-3/A | Amendment no. 1 to form f-3 | Dec 28, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 20, 2023 | Dec 20, 2023 |
| 6-K | Current report (foreign issuer) | Dec 18, 2023 | Dec 18, 2023 |
| F-3 | Shelf registration (foreign issuer) | Dec 12, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 4, 2023 | Dec 4, 2023 |
| 6-K | Current report (foreign issuer) | Nov 30, 2023 | Nov 30, 2023 |
| 424B3 | Prospectus | Nov 22, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 22, 2023 | Nov 22, 2023 |
| 6-K | Current report (foreign issuer) | Nov 21, 2023 | Nov 21, 2023 |
| 6-K | Current report (foreign issuer) | Nov 21, 2023 | Nov 21, 2023 |
| 6-K | Current report (foreign issuer) | Nov 1, 2023 | Nov 1, 2023 |
| 6-K | Current report (foreign issuer) | Oct 30, 2023 | Oct 30, 2023 |
| 6-K | Current report (foreign issuer) | Oct 26, 2023 | Oct 26, 2023 |
| 6-K | Current report (foreign issuer) | Oct 10, 2023 | Oct 10, 2023 |
| 6-K | Current report (foreign issuer) | Sep 27, 2023 | Sep 27, 2023 |
| EFFECT | Filing | Sep 12, 2023 | — |
| CORRESP | Letter to the SEC | Sep 11, 2023 | — |
| EFFECT | Filing | Sep 8, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CANF (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Ramat Gan, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1536196
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.